Jane Grogan
Direttore Tecnico/Scientifico/R&S presso BIOGEN INC.
Profilo
Jane Grogan is currently the Executive Vice President & Head-Research at Biogen, Inc. Prior to her current position, she worked at Genentech, Inc. as the Head-Adaptive Tumor Immunity & Principal Scientist from 2014 to 2019.
From 2019 to 2021, she was the Chief Scientific Officer at Arsenal Biosciences, Inc. She also served as the Chief Scientific Officer at Graphite Bio, Inc. Dr. Grogan received her undergraduate degree from the University of Melbourne and her doctorate from the University of Leiden.
Posizioni attive di Jane Grogan
| Società | Posizione | Inizio |
|---|---|---|
| BIOGEN INC. | Direttore Tecnico/Scientifico/R&S | 02/10/2023 |
Precedenti posizioni note di Jane Grogan
| Società | Posizione | Fine |
|---|---|---|
Arsenal Biosciences, Inc.
 Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Arsenal Biosciences, Inc. discovers, develops, and commercializes curative immune cell therapies. It offers cell therapy, cloud computing, computational biology, genome engineering, machine learning, software engineering, and synthetic immunology. The company was founded by Ken E. Drazan, Bradley E. Bernstein, W. Nicholas Haining, Theo Roth, Kole T. Roybal, and E. John Wherry and is headquartered in San Francisco, CA. | Direttore Tecnico/Scientifico/R&S | 01/03/2021 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/09/2019 |
| LENZ THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Jane Grogan
| University of Melbourne | Undergraduate Degree |
| University of Leiden | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA. | Health Technology |
Arsenal Biosciences, Inc.
Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Arsenal Biosciences, Inc. discovers, develops, and commercializes curative immune cell therapies. It offers cell therapy, cloud computing, computational biology, genome engineering, machine learning, software engineering, and synthetic immunology. The company was founded by Ken E. Drazan, Bradley E. Bernstein, W. Nicholas Haining, Theo Roth, Kole T. Roybal, and E. John Wherry and is headquartered in San Francisco, CA. | Technology Services |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Jane Grogan
